Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Or a false positive/publicity stunt? Who knows, definitely not US
The only thing I see as “brainless,” is asking why those States in particular. He didn’t attack anyone, for a lack of a better word(I find it hard to believe these letters on anyone’s screen can be deemed as “attacking” but that’s neither here nor there) is you. Typical
If they are, they’re just shorts
It can go either way, I was in GMGI and look how it’s done since the RS. Hackers then would say it wouldn’t qualify because it couldn’t hold a $3 trading price for a month and its outperformed that by a bit. It’s not always good but it’s not always bad either.m
RLFTF
Relief/NeuroRx finalize global commercialization deal for RLF-100 https://seekingalpha.com/news/3615552-relief-neurorx-finalize-global-commercialization-deal-for-rlfminus-100
With the surfactant produced in the alveoli type II from taking RLF-100, yes, yes it does. Searcy is clearly proof of this. Next...
RLFTF
RLFTF
Do you mind me asking which subscription you have/prefer?
I’d say he has connections at the least. From Neurorxpharma.com
Jonathan C. Javitt,
M.D., M.P.H.
Dr. Javitt has played leadership roles in seven successful healthcare IT and biopharma startups with public exits. He has additionally led drug-development engagements for Merck, Allergan, Pharmacia, Novartis, and Pfizer. He was appointed to healthcare leadership roles under Presidents Reagan, George H.W. Bush, Clinton, and George W. Bush. In the latter role he was commissioned to lead the White House policy for universal adoption of Health IT and establishment of the Office of the National Coordinator. He is a graduate of Princeton University, Cornell University Medical College, Harvard School of Public Health, the Wills Eye Hospital, and Johns Hopkins Medical School. Dr. Javitt has published more than 200 scientific works in the areas of health outcomes and pharmacoeconomics that have been cited by more than 16,000 people.
Key words I said *not just endorsements
He was put on their advisory boards not just endorsements
May or may no have sent some of your DD along with some of my own to Kevin Harrington. Seemed fitting since he’s gotten involved with KNO$ and OPT! and this is in the same ballpark as both and also their charts have been posted here so, I thought why the f not
I’m thinking this mornings action was FOMO on OPT*’s announcement of Kevin Harrington getting involved with their advisory board. Same sector (sanitization) just different. Also with referencing KNO$ he had also gotten involved with that one. Wouldn’t that be something if he were to get involved here or even another “shark” who has connections to brick and mortar stores all across the country/overseas
OPTI
Kevin Harrington on advisory board
OPTI
Kevin Harrington in advisory board
RBII
OTC Markets subscription is now current we will have access to the system shortly and will be able to upload financials at that time
— Rising Biosciences (@RisingBioscien1) July 24, 2020
Thanks again for your patience
RBII pic.twitter.com/1lD2YKigT8
RBII
OTC Markets subscription is now current we will have access to the system shortly and will be able to upload financials at that time
— Rising Biosciences (@RisingBioscien1) July 24, 2020
Thanks again for your patience
RBII pic.twitter.com/1lD2YKigT8
RBII
OTC Markets subscription is now current we will have access to the system shortly and will be able to upload financials at that time
— Rising Biosciences (@RisingBioscien1) July 24, 2020
Thanks again for your patience
RBII pic.twitter.com/1lD2YKigT8
RBII
OTC Markets subscription is now current we will have access to the system shortly and will be able to upload financials at that time
— Rising Biosciences (@RisingBioscien1) July 24, 2020
Thanks again for your patience
RBII pic.twitter.com/1lD2YKigT8
RBII
OTC Markets subscription is now current we will have access to the system shortly and will be able to upload financials at that time
— Rising Biosciences (@RisingBioscien1) July 24, 2020
Thanks again for your patience
RBII pic.twitter.com/1lD2YKigT8
Surfactant
“Surfactants are compounds that lower the surface tension between two liquids, between a gas and a liquid, or between a liquid and a solid. Surfactants may act as detergents, wetting agents, emulsifiers, foaming agents, and dispersants. The word surfactant is a blend of surface-active agent.”
RBII
Good morning everybody I just wanted to let everyone know that we are working diligently with OTC Markets and should be able to get the financials uploaded shortly and the stop sign removed ASAP
— Rising Biosciences (@RisingBioscien1) July 23, 2020
Thank you for your patience
Arthur Hall CEO#RBII
RBII
Good morning everybody I just wanted to let everyone know that we are working diligently with OTC Markets and should be able to get the financials uploaded shortly and the stop sign removed ASAP
— Rising Biosciences (@RisingBioscien1) July 23, 2020
Thank you for your patience
Arthur Hall CEO#RBII
They’re hiring if anyone lost too much on the stock :D
RBII
Check out this job on Indeed:
Oxi-Thyme South East
Sales Representative
Anchorage, AK
https://www.indeed.com/m/viewjob?jk=c51b383a67fda3c3&from=native
RBII
SANDUSKY, OH / ACCESSWIRE / July 17, 2020 / Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall announced significant revenue growth to nearly $350,000 in Q2 as sales and reception of the company's Oxi Thyme have escalated dramatically. "The activity over the last three months has been incredible", said Hall. "We have already outgrown our original bottling plant and are in the process of building a second bottling facility in South Florida . Currently, we are operating in 14 states, servicing 74 regions from Anchorage, AK to Key West, FL , with more going on line each week." Oxi Thyme has introduced a proprietary system designed to sanitize and disinfect varying facilities in the current challenging environment, quickly and cost effectively. Utilizing a proprietary formulated EPA registered Hydrogen Peroxide disinfectant, developed with a surfactant, or surface active agent, Oxi Thyme improves efficiency by lowering surface tension. The addition of a surfactant and the use of an atomizing ULV (ultra low volume) or HVLP (high volume, low pressure) fogging system allows the droplets of disinfectant to disperse more evenly and cover larger surface areas, creating a no touch solution to sanitizing large areas quickly and efficiently leaving no toxic residue. "We are living in challenging times", Hall added, "and experiencing a dramatic climate of change with this Covid-19 pandemic. People are struggling to establish what our new normal will be with respect to safety standards. Oxi Thyme has heard the call and we are here to help!" About Rising Biosciences, Inc. About Rising Biosciences Inc. - In addition to Oxi Thyme, RBII operates three distinct business units. The first business unit is a physicians practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The second business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA. The third business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest. Follow $RBII on the NEW Twitter account and on Facebook for LIVE updates! https://twitter.com/RisingBioscien1 https://www.facebook.com/RisingBioSciences/ Cautionary Statement Regarding Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release. CONTACT INFO: For Investor Inquiries: IR@risingbiosciences.com SOURCE: Rising Biosciences, Inc. View source version on accesswire.com: https://www.accesswire.com/597805/Rising-Biosciences-Inc-Propels-Q2-Revenues-to-Nearly-350000-Due-to-Exceptional-Growth-of-Oxi-Thyme-Division
He mentioned uplisting, nothing more nothing less.
GMGID/GMGI
Golden Matrix Completes 1-for-150 Reverse Stock Split
“Las Vegas, NV - (NewMediaWire) - June 29, 2020 - Golden Matrix Group Inc. (OTC: GMGID), a developer and licenser of social gaming platforms, systems and gaming content, today announced the company has completed its 1-for-150 reverse stock split, and the split-adjusted shares began trading on June 26, 2020. The common shares, which previously traded under the ticker symbol "GMGI," are trading on a post-split basis under the symbol "GMGID." They will continue to trade for a period of 20 business days, after which time the "D" will be removed, and the symbol will revert back to "GMGI."
The reverse stock split affected all issued and outstanding shares of GMGI common stock and will not alter any stockholder's percentage interest in GMGI's equity. No fractional shares have been issued in connection with the reverse split, and shareholders who would be entitled to receive a fractional share have instead received one additional share.
"We are extremely pleased by the success of the reverse split," said Golden Matrix CEO Brian Goodman. "It is an important step in our long-term strategy to build Golden Matrix into an international company and represents our commitment to enhance shareholder value and uplist GMGI shares to a national exchange later this year. Also, we believe that the company's continuing profitability and expansion of product offerings and geographic reach, coupled with a more attractive capitalization, will engage the interest of a broader range of investors and attract new shareholders."
Mr. Goodman noted that, as a result of the 1-for-150 reverse split, the company's outstanding common stock was reduced to about 19 million shares from almost 3 billion shares, and the number of authorized shares were reversed at the same ratio and reduced to 40 million shares from 6 billion shares.
“Golden Matrix revenues are derived primarily from licensing fees received from gaming operators located in the Asia Pacific (APAC) region and integrated with the company's state-of-the-art GM-X platform. The company reported earlier this month that there are now more than three million registered users across all GM-X gaming platforms. "As a result of the rapid expansion of active users these past few months," said Mr. Goodman, "we expect June to be a record revenue month and the current quarter to finish strongly with increased revenues and profitability."
About Golden Matrix
Golden Matrix Group, based in Las Vegas, NV, is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located primarily in the Asia Pacific region. The gaming IP includes tools for marketing, acquisition, retention, and monetization of users. The company's platform can be accessed through both desktop and mobile applications.
Our sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current US law.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.”
GMGID/GMGI
Golden Matrix Completes 1-for-150 Reverse Stock Split
“Las Vegas, NV - (NewMediaWire) - June 29, 2020 - Golden Matrix Group Inc. (OTC: GMGID), a developer and licenser of social gaming platforms, systems and gaming content, today announced the company has completed its 1-for-150 reverse stock split, and the split-adjusted shares began trading on June 26, 2020. The common shares, which previously traded under the ticker symbol "GMGI," are trading on a post-split basis under the symbol "GMGID." They will continue to trade for a period of 20 business days, after which time the "D" will be removed, and the symbol will revert back to "GMGI."
The reverse stock split affected all issued and outstanding shares of GMGI common stock and will not alter any stockholder's percentage interest in GMGI's equity. No fractional shares have been issued in connection with the reverse split, and shareholders who would be entitled to receive a fractional share have instead received one additional share.
"We are extremely pleased by the success of the reverse split," said Golden Matrix CEO Brian Goodman. "It is an important step in our long-term strategy to build Golden Matrix into an international company and represents our commitment to enhance shareholder value and uplist GMGI shares to a national exchange later this year. Also, we believe that the company's continuing profitability and expansion of product offerings and geographic reach, coupled with a more attractive capitalization, will engage the interest of a broader range of investors and attract new shareholders."
Mr. Goodman noted that, as a result of the 1-for-150 reverse split, the company's outstanding common stock was reduced to about 19 million shares from almost 3 billion shares, and the number of authorized shares were reversed at the same ratio and reduced to 40 million shares from 6 billion shares.
Golden Matrix revenues are derived primarily from licensing fees received from gaming operators located in the Asia Pacific (APAC) region and integrated with the company's state-of-the-art GM-X platform. The company reported earlier this month that there are now more than three million registered users across all GM-X gaming platforms. "As a result of the rapid expansion of active users these past few months," said Mr. Goodman, "we expect June to be a record revenue month and the current quarter to finish strongly with increased revenues and profitability."
About Golden Matrix
Golden Matrix Group, based in Las Vegas, NV, is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located primarily in the Asia Pacific region. The gaming IP includes tools for marketing, acquisition, retention, and monetization of users. The company's platform can be accessed through both desktop and mobile applications.
Our sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current US law.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.”